Sun, Y <br/><br/>
Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study.  [electronic resource] 

 -  Gene therapy  Apr 1998 
 - 481-90 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0969-7128 
<br/><br/><label>Standard No.: </label>10.1038/sj.gt.3300619  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biolistics<br/>Cancer Vaccines<br/>Female<br/>Gene Transfer Techniques<br/>Genetic Therapy--methods<br/>Humans<br/>Hypersensitivity, Delayed<br/>Immunohistochemistry<br/>Interleukin-10--metabolism<br/>Interleukin-12--genetics<br/>Killer Cells, Natural--immunology<br/>Male<br/>Melanoma--immunology<br/>Middle Aged<br/>Polymerase Chain Reaction<br/>T-Lymphocytes--immunology<br/>Transforming Growth Factor beta--metabolism<br/>Tumor Cells, Cultured